These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus. Wolff M; Mourvillier B Clin Infect Dis; 2012 Jul; 55(1):160-1. PubMed ID: 22460958 [No Abstract] [Full Text] [Related]
25. Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly. Kollef MH Crit Care Med; 2012 Jan; 40(1):330-2. PubMed ID: 22179367 [No Abstract] [Full Text] [Related]
26. A refractory case of community-acquired pneumonia. Schlaudecker JD J Fam Pract; 2009 Nov; 58(11):573-5. PubMed ID: 19891934 [No Abstract] [Full Text] [Related]
27. Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Bender JW; Hughes WT Johns Hopkins Med J; 1980 Jan; 146(1):13-5. PubMed ID: 6986499 [TBL] [Abstract][Full Text] [Related]
28. [Study on 85 cases of aureus staphylococcal pneumonia (author's transl)]. Zhang CD Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Sep; 3(3):169-71. PubMed ID: 7227119 [No Abstract] [Full Text] [Related]
29. Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia. Potoski BA; Paterson DL Chest; 2007 Sep; 132(3):1101-2; author reply 1102-3. PubMed ID: 17873215 [No Abstract] [Full Text] [Related]
30. Should we abandon vancomycin for treatment of methicillin-resistant Staphylococcus aureus pneumonia? Still questions to answer. Taccone FS; Vincent JL; Denis O; Jacobs F Clin Infect Dis; 2012 Jul; 55(1):161-3; author reply 163-5. PubMed ID: 22460955 [No Abstract] [Full Text] [Related]
31. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Estes L; Orenstem R Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300 [No Abstract] [Full Text] [Related]
33. [The prognosis of abscessing pneumonia in infancy]. Dietel K; Mühle H Med Klin; 1967 Dec; 62(52):2029-31. PubMed ID: 5596498 [No Abstract] [Full Text] [Related]
34. [Pediatric guidelines. 4. Antibiotic therapy of meningitis purulenta, sepsis and staphylococcal pneumonia]. Ocklitz HW; Schmitz HH; Schmidt EF Z Arztl Fortbild (Jena); 1968 Oct; 62(20):1118-21. PubMed ID: 5731177 [No Abstract] [Full Text] [Related]
35. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: controversy continues. Masuta K; Oba Y; Iwata K Clin Infect Dis; 2012 Jul; 55(1):161. PubMed ID: 22460960 [No Abstract] [Full Text] [Related]
36. Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-acquired Staphylococcus aureus in adult and adolescent patients. Li HT; Zhang TT; Huang J; Zhou YQ; Zhu JX; Wu BQ Respiration; 2011; 81(6):448-60. PubMed ID: 21051855 [TBL] [Abstract][Full Text] [Related]
37. [Study of beta-lactamase activity of staphylococci from different sources]. Ermolina GB; Degteva GK; Nosova TV; Shubina ZV Antibiot Khimioter; 1991 Feb; 36(2):19-21. PubMed ID: 2025111 [TBL] [Abstract][Full Text] [Related]
38. Using cheaper antibiotics to treat MRSA infection in India. Banerjee A BMJ; 2014 Apr; 348():g2448. PubMed ID: 24699127 [No Abstract] [Full Text] [Related]